People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

When a nosebleed hits, we often go into panic mode. We frantically reach for tissues and may try shoving them up in our ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

An ear, nose and throat doctor explains why tipping your head back with a nosebleed could make things worse and what you ...

A nasal rinse is a common practice to clear nasal passages, especially during cold, flu, and allergy seasons. Here's who can ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

If you are severely congested, here's one move to clear a stuffy nose. It works so well, you'll want to bookmark this video.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...